ERBB2 and neoplasm: As desired, these Ab-mI2XCy-Ac conjugates displayed negligible side effects and promising tumor growth inhibition in the Her2 positive BT-474 tumor mouse model, which is almost the same as for the permanently active antibody–PS conjugates (Ab-mI2XCy) [127].